Clinical Trials for Leman Biotech

Explore 7 clinical trials worldwide

Showing 1-7 of 7 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruitingSponsor: Leman Biotech

Clinical Trials (7)

NCT07106814
Safety and Efficacy of Metabolically Armed Tumor-lnfiltrating Lymphocytes (Meta10-TIL) for the Treatment of Advanced Solid Tumors
EARLY_PHASE1Recruiting
36 participants
Started: Aug 29, 2025 · Completed: Dec 30, 2027
1 condition2 sponsors1 location
NCT07085559
Safety and Efficacy of Metabolically Armed BCMA CAR-T Cells (Meta10-BCMA) in the Treatment of r/r Plasma Cell Neoplasms Clinical Research
EARLY_PHASE1Recruiting
36 participants
Started: Jun 23, 2025 · Completed: Oct 15, 2027
3 conditions2 sponsors1 location
NCT06711146
Safety and Efficacy of Metabolically Armed CD19 CAR-T Cells (Meta10-19) in the Treatment of Moderate to Severe Active SLE Clinical Research
EARLY_PHASE1Recruiting
36 participants
Started: Feb 10, 2025 · Completed: Apr 5, 2027
1 condition2 sponsors1 location
NCT06716164
Safety and Efficacy of Metabolically Armed CD19 CAR-T Cells (Meta10-19) in the Treatment of r/r B-NHL Clinical Research
EARLY_PHASE1Recruiting
36 participants
Started: Dec 1, 2024 · Completed: Apr 5, 2027
1 condition2 sponsors1 location
NCT06393335
Safety and Efficacy of Metabolically Armed CD19 CAR-T Cells (Meta10-19) in the Treatment of Relapsed and/or Refractory CD19-positive B Cell Hematological Malignancies Clinical Research
EARLY_PHASE1Recruiting
36 participants
Started: May 15, 2024 · Completed: Mar 15, 2026
2 conditions2 sponsors1 location
NCT06120166
Safety and Efficacy of Metabolically Armed CD19 CAR-T Cells (Meta10-19) in the Treatment of r/r DLBCL Clinical Research
EARLY_PHASE1Recruiting
18 participants
Started: Nov 16, 2023 · Completed: Apr 5, 2026
1 condition2 sponsors1 location
NCT06277011
Safety and Efficacy of Metabolically Armed CD19 CAR-T Cells (Meta10-19) in the Treatment of Relapsed and/or Refractory CD19-positive B Cell Hematological Malignancies Clinical Research
EARLY_PHASE1Recruiting
18 participants
Started: Feb 10, 2023 · Completed: May 15, 2025
2 conditions2 sponsors1 location